The committee will be choosing up to 20 oral presentation from abstracts submitted via this website. The data in these abstracts must not have been previously published.

To submit electronically please click on the button at the bottom of the page and follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

The deadline for abstract submission is Friday, March 31, 2006. All submissions should not exceed 450 words.

ABSTRACT GUIDELINES

Format
The body of the uploaded abstract submission should not exceed 450 words; this limit excludes the title, authors and affiliations.

Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:

Title (not included in 450 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Authors/Affiliations (not included in 450 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. AN Author1, AN Author2 and AN Author3).

All author affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France.

Background
State the problem under investigation or a hypothesis. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Methods
Explain the experimental methods used. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.

Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.


ADDITIONAL ABSTRACT INFORMATION

In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form:

Contact Information
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily.

Form of Presentation
up to 20 oral presentations will be selected from the submitted abstracts.

Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.

• Emerging viruses
• HBV
• HCV
• HIV

Abstract Title (same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).

Sample Abstract

To view a sample abstract, click here.

The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.


ABSTRACT NOTIFICATIONS

Notifications of acceptance and format of presentation (oral or poster presentation) will be April 4, 2006. It is the responsibility of the corresponding/presenting author to inform all co-authors of the disposition status. If you have not received notification by Tuesday, April 4, 2006, please call +1 770 997 2484.

If an abstract is accepted, one author is required to register for the conference and present the poster as scheduled.

Guidelines for preparing your poster presentations will be sent if your abstract is accepted.


PUBLISHED ABSTRACT BOOK

Accepted abstracts will be standardized in font and presentation. Any error that appears in the submitted abstract may appear in the printed abstract.

Subject to availability, copies of the Abstract Book will be available for sale after the Conference. Please contact the Conference Secretariat.

Copyright © 2006 Informed Horizons, LLC
All rights reserved, additional copyright information also applies.